Today's Low | Today's High | |
---|---|---|
84.71 84.78 |
| 87.50 87.65 |
52 Week Low | 52 Week High | |
---|---|---|
38.55 (14-Mar-2024) 38.56 (13-Mar-2024) |
| 100.90 (10-Sep-2024) 100.80 (10-Sep-2024) |
Buy Order Quantity | Sell Order Quantity | |
---|---|---|
28,924 | 0 |
Bid Price | Quantity |
---|---|
85.80 | 28,924.00 |
0.00 | 0.00 |
0.00 | 0.00 |
0.00 | 0.00 |
0.00 | 0.00 |
Total: | 28,924 |
Ask Price | Quantity |
---|---|
0.00 | 0.00 |
0.00 | 0.00 |
0.00 | 0.00 |
0.00 | 0.00 |
0.00 | 0.00 |
Total: | -- |
Market Cap: | ₹47.10 Cr |
PE Ratio (TTM): | 33.15 |
PB Ratio: | 4.10 |
Industry P/E: | 36.28 |
Debt to Equity: | - |
ROE: | 12.38 |
EPS (TTM): | 2.59 |
Book Value: | 0.00 |
Face Value: | 2.00 |
Jun, 2023 | Jun, 2022 | Jun, 2023 | Jun, 2023 | Jun, 2023 | |
---|---|---|---|---|---|
Revenue | 158.39 Cr | 42.62 Cr | 74.95 Cr | 55.62 Cr | 369.10 Cr |
Profit | 23.72 Cr | -18.68 Cr | 5.24 Cr | 5.57 Cr | 15.85 Cr |
Expense | 126.60 Cr | 62.36 Cr | 69.18 Cr | 48.21 Cr | 349.47 Cr |
Comprehensive income | 23.73 Cr | -18.76 Cr | 5.28 Cr | 5.26 Cr | 16.94 Cr |
EPS | 3.49 | -14.30 | 3.44 | 2.44 | 0.31 |
Company name | Listing date | Industry | NSE symbol BSE symbol |
---|---|---|---|
Morepen Laboratories Limited | Nov, 1999 Mar, 1993 | Pharmaceuticals Pharmaceuticals | MOREPENLAB MOREPENLAB |
Promoters | |
---|---|
38.22% |
Public | |
---|---|
61.78% |
Shares held by Employee Trusts | |
---|---|
0.00% |
Promoters | |
---|---|
38.22% |
Public | |
---|---|
61.78% |
Shares held by Employee Trusts | |
---|---|
0.00% |
Promoters | |
---|---|
38.22% |
Public | |
---|---|
61.78% |
Shares held by Employee Trusts | |
---|---|
0.00% |
Promoters | |
---|---|
38.22% |
Public | |
---|---|
61.78% |
Shares held by Employee Trusts | |
---|---|
0.00% |
Promoters | |
---|---|
38.22% |
Public | |
---|---|
61.78% |
Shares held by Employee Trusts | |
---|---|
0.00% |
Today's stock performance witnessed a fluctuation from a minimum of 84.71 on the NSE (National Stock Exchange) to a maximum of 87.50. Similarly, on the BSE (Bombay Stock Exchange), the stock's intraday range extended from a low of 84.78 to a high of 87.65.
The stock's performance over the past 52 weeks reveals a low of 38.55 (occurred on 14-Mar-2024) and a high of 100.90 (achieved on 10-Sep-2024) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 38.56 (on 13-Mar-2024), and the 52-week high is 100.80 (on 10-Sep-2024).
The stock's performance over the past 52 weeks reveals a low of 38.55 (occurred on 14-Mar-2024) and a high of 100.90 (achieved on 10-Sep-2024) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 38.56 (on 13-Mar-2024), and the 52-week high is 100.80 (on 10-Sep-2024).
The total volume is 57, and the total traded value is 48.70 (₹ Lakhs).
The upper circuit limit is 104.67, and the lower circuit limit is 69.78.
The market cap is ₹47.10 Cr, and the PE ratio (TTM) is 36.28.
ROE is 12.38, EPS is 2.59, book value is not available
In Jun 2023, Revenue is ₹1583865000.00, and Profit is ₹237173000.00. In Jun 2022, Revenue is ₹426221000, and Profit is ₹-186836000.
The company, Morepen Laboratories Limited, was listed in Nov 1999 and belongs to the Pharmaceuticals industry. Its NSE symbol is MOREPENLAB.
As of latest available update, promoters hold 38.22%, the public holds 61.78%, and Employee Trusts holds 0.00.
Discover the vibrant tapestry of 'The Indian Community' - a melting pot of diverse cultures, traditions, and values. Explore its rich heritage, festivals, and contributions, as this online hub celebrates the essence of India's people, connecting, inspiring, and fostering unity worldwide.